US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

KraneShares MSCI All China Health Care Index ETF

17.74

-0.0600-0.34%

Post-market: 17.800.0600+0.34%19:30 EDT

Volume:28.78K

Turnover:509.79K

Market Cap:104.67M

PE:- -

High:17.93

Open:17.89

Low:17.60

Close:17.80

52wk High:21.50

52wk Low:14.38

Shares:5.90M

Float Shares:5.90M

Volume Ratio:0.55

T/O Rate:0.49%

Dividend:0.71

Dividend Rate:4.03%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China

THOMSON REUTERS

CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points

CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials

MT Newswires Live

CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops

CSPC Pharmaceutical - Syh2083 Eye Drops Obtain Clinical Trial Approval in China

THOMSON REUTERS

Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong

CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors

Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval

CSPC Pharma Begins Phase II Study of Influenza Drug in China

MT Newswires Live

Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC

WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares

CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults

Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong

UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts

Hong Kong Stock Connect Biotech Surges: Dual-Antibody Outperforms Keytruda, Sector Heats Up

Loose Fed Bets and AI Monetization Fuel Hong Kong Stocks Rally

WuXi Bio Issues 3.2 Million Shares Following Option Exercise

Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets

MT Newswires Live

Daiwa Highlights AKESO's HARMONi-2 Milestone, Bolstering Case for Global NSCLC Study Success

Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrzen.com/stock/KURE/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"KURE","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","market":"US","secType":"STK","nameCN":"KraneShares MSCI All China Health Care Index ETF","latestPrice":17.74,"timestamp":1789156800000,"preClose":17.8,"halted":0,"volume":28778,"hourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"delay":0,"changeRate":-0.00337078651685406,"floatShares":5900168,"shares":5900168,"eps":0,"marketStatus":"Not Yet Opened","change":-0.06,"latestTime":"09-11 16:00:00 EDT","open":17.89,"high":17.93,"low":17.6,"amount":509789.147232,"amplitude":0.018539,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1789372800000},"marketStatusCode":0,"adr":0,"adrRate":0,"exchange":"ARCA","adjPreClose":17.8,"sharesOutstanding":4750002,"nav":17.75,"aum":104708978.23,"dividendRate":0.040293,"bidAskSpread":0.008219,"postHourTrading":{"tag":"盘后","latestPrice":17.8,"preClose":17.74,"latestTime":"19:30 EDT","volume":110,"amount":1957.48,"timestamp":1789169406504,"change":0.06,"changeRate":0.003382,"amplitude":0.003382},"volumeRatio":0.5515710695008692,"impliedVol":0.3113,"impliedVolPercentile":0.636},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"KURE\",,,,,undefined,":{"symbol":"KURE","floatShares":5900168,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.5515710695008692,"shares":5900168,"dividePrice":0.7148,"high":17.93,"amplitude":0.018539,"preClose":17.8,"low":17.6,"week52Low":14.3797,"pbRate":"--","week52High":21.5,"institutionHeld":0,"latestPrice":17.74,"eps":0,"divideRate":0.040293,"volume":28778,"delay":0,"ttmEps":0,"open":17.89,"prevYearClose":17.04,"prevWeekClose":18.9,"prevMonthClose":18.54,"prevQuarterClose":15.747,"fiveDayClose":18.91,"twentyDayClose":18.66,"sixtyDayClose":14.875},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/KURE\",params:#limit:5,,,undefined,":[{"date":"2025-12-22","symbol":"KURE","amount":0.714689,"announcedDate":"2025-12-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-22","defaultRemindTime":1766413800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-23","payableDate":"2025-12-22","currency":"USD","dateTimestamp":1766379600000,"payDate":"2025-12-23"},{"date":"2024-12-17","symbol":"KURE","amount":0.18361,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"KraneShares MSCI All China Health Care Index ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-18","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-18"},{"date":"2023-12-18","symbol":"KURE","amount":0.112844,"announcedDate":"2023-12-15","type":"dividend","market":"US","newRecordDate":"2023-12-19","defaultRemindTime":1702909800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2023-12-20","payableDate":"2023-12-19","currency":"USD","dateTimestamp":1702875600000,"payDate":"2023-12-20"},{"market":"US","date":"2022-12-28","symbol":"KURE","amount":0.010399,"defaultRemindTime":1672237800000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2022-12-30","payableDate":"2022-12-29","currency":"USD","type":"dividend","dateTimestamp":1672203600000},{"market":"US","date":"2021-12-29","symbol":"KURE","amount":4.053448,"defaultRemindTime":1640788200000,"name":"KraneShares MSCI All China Health Care Index ETF","recordDate":"2021-12-31","payableDate":"2021-12-30","currency":"USD","type":"dividend","dateTimestamp":1640754000000}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"KURE\",market:\"US\",,,undefined,":[{"executeDate":"2018-12-26","recordDate":"2018-12-27","paymentDate":"2018-12-28","value":0.039344,"currency":"USD"},{"executeDate":"2019-12-27","recordDate":"2019-12-30","paymentDate":"2019-12-31","value":0.057325,"currency":"USD"},{"executeDate":"2020-12-29","recordDate":"2020-12-30","paymentDate":"2020-12-31","value":0.000109,"currency":"USD"},{"executeDate":"2021-12-29","recordDate":"2021-12-30","paymentDate":"2021-12-31","value":4.053448,"currency":"USD"},{"executeDate":"2022-12-28","recordDate":"2022-12-29","paymentDate":"2022-12-30","value":0.010399,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"KURE\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"KURE\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666584556","title":"CSPC Pharmaceutical - Goserelin Sustained-Release Injection (Syh9102 Injection) Obtains Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2666584556","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666584556?lang=en_us&edition=fundamental","pubTime":"2026-09-09 18:07","pubTimestamp":1788948434,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260909:nFWN450126:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU2039709279.SGD","01093","LU0072913022.USD","LU1226288170.HKD","LU0314109678.HKD","IE00B543WZ88.USD","LU0315179316.USD","IE0008369823.USD","LU1226288253.USD","IE0008368742.USD","LU1226287792.SGD","LU1807302812.USD","BK1521","LU1813983027.USD","LU1008478684.HKD","LU1951186391.HKD","IE00B5MMRT66.SGD","BK1191","LU1152091754.HKD","LU0501845795.SGD","IE00B031HY20.USD","LU1328277881.USD","LU0880133367.SGD","IE00BZ08YT58.USD","LU0140636845.USD","IE00BZ08YS42.EUR","LU1152091168.USD","LU1226287875.USD","SG9999004220.SGD","IE00BZ08YR35.GBP","LU1993786604.SGD","HK0000165453.HKD","LU0067412154.USD","BK1515","KURE","LU0326950275.SGD","LU1960683339.HKD","LU1226287529.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191216573","title":"CLSA Highlights Return of Stock-Specific Drivers in China's Innovative Drug Sector, Sees Macro Swings as Entry Points","url":"https://stock-news.laohu8.com/highlight/detail?id=1191216573","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1191216573?lang=en_us&edition=fundamental","pubTime":"2026-09-09 14:06","pubTimestamp":1788933977,"startTime":"0","endTime":"0","summary":"China's innovative drug sector is swinging back to a market led by company fundamentals and stock-specific alpha, according to a research note from CLSA. The influence of particular company...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","03692","KURE","BK1589","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665214203","title":"CSPC Pharmaceutical Gets China Approval for Eye Drug Clinical Trials","url":"https://stock-news.laohu8.com/highlight/detail?id=2665214203","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665214203?lang=en_us&edition=fundamental","pubTime":"2026-09-08 18:13","pubTimestamp":1788862439,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group's (HKG:1093) SYH2083 eye drops received approval from the National Medical Products Administration to begin clinical trials in China.The class 1 innovative drug is being developed for dry eye disease, according to a Tuesday Hong Kong bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0501845795.SGD","IE00B5MMRT66.SGD","LU2039709279.SGD","BK1191","IE00BZ08YS42.EUR","LU1152091168.USD","LU0067412154.USD","LU1226287792.SGD","LU0072913022.USD","LU1226287875.USD","IE00B031HY20.USD","LU1807302812.USD","01093","BK1521","KURE","LU1152091754.HKD","LU1813983027.USD","SG9999004220.SGD","LU1951186391.HKD","LU0880133367.SGD","LU0315179316.USD","IE00B543WZ88.USD","LU0326950275.SGD","IE00BZ08YR35.GBP","IE0008368742.USD","LU1226288170.HKD","LU0314109678.HKD","LU1960683339.HKD","LU1993786604.SGD","LU1226287529.USD","BK1515","IE00BZ08YT58.USD","LU0140636845.USD","LU1226288253.USD","IE0008369823.USD","LU1008478684.HKD","LU1328277881.USD","HK0000165453.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329613","title":"CSPC Wins China Clinical Trial Approval for Syh2083 Dry Eye Drops","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329613","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329613?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860844,"startTime":"0","endTime":"0","summary":"CSPC wins China clinical trial approval for SYH2083 dry eye dropsCSPC received China NMPA clearance to start clinical trials of SYH2083 eye drops, a small-molecule novel drug.Initial indication target","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nNDL4D1fT5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU0326950275.SGD","BK1521","LU1226288170.HKD","LU1993786604.SGD","LU0315179316.USD","IE00BZ08YS42.EUR","LU1226288253.USD","LU1152091754.HKD","SG9999004220.SGD","KURE","IE0008368742.USD","BK1515","LU0072913022.USD","LU1328277881.USD","LU0067412154.USD","LU1951186391.HKD","LU0314109678.HKD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1008478684.HKD","BK1191","HK0000165453.HKD","LU1152091168.USD","IE0008369823.USD","IE00BZ08YT58.USD","01093","LU0501845795.SGD","LU0880133367.SGD","LU1226287875.USD","IE00B5MMRT66.SGD","IE00B543WZ88.USD","LU2039709279.SGD","LU1960683339.HKD","LU0140636845.USD","LU1226287792.SGD","LU1813983027.USD","LU1807302812.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665329660","title":"CSPC Pharmaceutical - Syh2083 Eye Drops Obtain Clinical Trial Approval in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2665329660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665329660?lang=en_us&edition=fundamental","pubTime":"2026-09-08 17:47","pubTimestamp":1788860822,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260908:nFWN44Z0GM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU1807302812.USD","LU1226288253.USD","IE00B031HY20.USD","LU0501845795.SGD","LU1008478684.HKD","LU2039709279.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU0072913022.USD","SG9999004220.SGD","LU1152091754.HKD","IE00BZ08YS42.EUR","KURE","LU0140636845.USD","LU1226288170.HKD","LU1813983027.USD","IE0008369823.USD","01093","IE00B5MMRT66.SGD","LU0314109678.HKD","LU0880133367.SGD","BK1515","HK0000165453.HKD","LU1328277881.USD","BK1191","LU1152091168.USD","IE00BZ08YR35.GBP","LU1226287529.USD","LU1226287792.SGD","LU1951186391.HKD","IE00B543WZ88.USD","IE0008368742.USD","BK1521","LU1993786604.SGD","LU0326950275.SGD","LU1226287875.USD","LU0315179316.USD","LU1960683339.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665399325","title":"Wuxi Biologics (Cayman) Stock Climbs 1.7% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665399325","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665399325?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:33","pubTimestamp":1788856380,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. rose 1.7% to 49.30 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.The stock's rise snapped a two-day losing streak.Wuxi Biologics  Inc. closed 9.5% short of its 52-week high of HK$54.45, which the company achieved Aug. 26.Trading volume totaled 22.4 million shares, compared to the 50-day average of 38.4 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1521","LU0588546209.SGD","LU1242518931.SGD","LU0052750758.USD","LU1794554557.SGD","LU2039709279.SGD","LU1688375341.USD","BK1141","LU1880383366.USD","LU0417516738.SGD","SG9999002562.SGD","LU0823426308.USD","LU0326950275.SGD","LU0348735423.USD","LU0708995583.HKD","LU0979878070.USD","LU0572944931.SGD","LU3063872942.SGD","LU0516423174.USD","LU0039217434.USD","LU0359201612.USD","SG9999002463.SGD","LU0516423091.SGD","LU0359202008.SGD","LU0417516902.SGD","LU0043850808.USD","LU1242518857.USD","LU0516422952.EUR","LU0051755006.USD","LU0348825331.USD","LU0823426480.USD","02269","LU0819121731.USD","LU1720050803.USD","LU0456846285.SGD","LU0140636845.USD","LU0516422440.USD","LU0029874061.USD","IE00B0JY6N72.USD","LU0456827905.SGD","LU0181495838.USD","BK1610","LU0320764599.SGD","LU0856984785.SGD","KURE","BK1589","BK1576","LU0516422366.SGD","LU0307460666.USD","LU0327786744.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665325339","title":"CSPC Pharmaceutical Group Stock Falls 2.7% in Hong Kong, Underperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2665325339","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665325339?lang=en_us&edition=fundamental","pubTime":"2026-09-08 16:32","pubTimestamp":1788856320,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. slid 2.7% to 9.42 Hong Kong dollars on what proved to be an all-around rough trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25317.18.This was the stock's second consecutive day of losses.CSPC Pharmaceutical Group Ltd. closed 19% short of its 52-week high of HK$11.63, which the company reached Sept. 9.The stock underperformed when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 6.9%, SSY Group Ltd. fell 0.9%, and United Laboratories International Holdings Ltd. rose 0.5%.Trading volume totaled 71.8 million shares, compared to the 50-day average of 105.6 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","IE0008368742.USD","BK1521","LU1960683339.HKD","LU0315179316.USD","LU0880133367.SGD","01093","HK0000165453.HKD","IE00B031HY20.USD","LU0326950275.SGD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1951186391.HKD","LU0072913022.USD","IE0008369823.USD","LU1226288253.USD","KURE","LU1993786604.SGD","LU2039709279.SGD","IE00BZ08YT58.USD","LU0314109678.HKD","LU0140636845.USD","LU0067412154.USD","LU0501845795.SGD","LU1226288170.HKD","BK1515","IE00B5MMRT66.SGD","SG9999004220.SGD","LU1328277881.USD","LU1152091754.HKD","LU1807302812.USD","IE00B543WZ88.USD","LU1226287875.USD","LU1813983027.USD","LU1226287529.USD","LU1008478684.HKD","LU1152091168.USD","IE00BZ08YS42.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1161695676","title":"Market Bets on BOJ Rate Hike While CICC's Merger Wins Regulatory Approval","url":"https://stock-news.laohu8.com/highlight/detail?id=1161695676","media":"Stock News","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1161695676?lang=en_us&edition=fundamental","pubTime":"2026-09-08 07:46","pubTimestamp":1788824797,"startTime":"0","endTime":"0","summary":"The National Copyright Administration has issued the \"15th Five-Year Plan for Copyright Work,\" outlining key targets through 2030. The plan sets a national work registration target of 9.5 million...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EXUS","IFLO","LU2663582299.SGD","LU0072913022.USD","OAKI","LU0501845795.SGD","09678","BK1501","PDEV","BK1249","LU0315179316.USD","CVIE","FNDC","BK1191","IE00BZ08YR35.GBP","SG9999004220.SGD","LU1993786604.SGD","IBFR","BK0276","BK1193","EFV","YDEC","BK4585","IE00B543WZ88.USD","TLTD","LU1807302812.USD","YJUN","RINT","EFAD","IE00B031HY20.USD","BK4588","JDVI","LU1226287792.SGD","IDLB","BK1109","IAUG","KCAI","DFAI","CGXU","DWM","IE00BZ08YS42.EUR","FNDF","NIHI","BK4550","FDT","AFDM","IAGG","IVSX","DFIV","FDEV","IBUF","IQLT","09976","HK0000165453.HKD","VDV","GWX","LU0880133367.SGD","BK1515","SG9999002828.SGD","IDVY","AVDE","LU0140636845.USD","LU0359201885.HKD","MTRA","GAID","HSCZ","IJUL","VIGI","LU1226287529.USD","DNL","IDYN","LU0067412154.USD","LU0326950275.SGD","BK1533","JIDE","LU1008478684.HKD","LU1580142542.USD","IE00BZ08YT58.USD","FIDI","LU1813983027.USD","BK1564","EFAV","WCMI","LU1508157978.USD","IE00B5MMRT66.SGD","HDMV","IDHQ","BK1149","DBAW","IE0008368742.USD","IDLV","BK1521","DFGX","IE0008369823.USD","IQDG","LU1781817850.SGD","REFA","BUFI","LU1226288170.HKD","LU1023057109.AUD","BK1147","LU0314109678.HKD","LU1328277881.USD","LU1951186391.HKD","BK1516","601995","LU1226287875.USD","NISM","NTSI","LU1960683339.HKD","PDN","PIEQ","DIVI","IFEB","EPIN","BK1122","LU0359201612.USD","LU1255011170.USD","LU1655091616.SGD","LU0359202008.SGD","BCIL","IJAN","03908","EFAS","LU2039709279.SGD","AVIV","OSEA","LU1152091168.USD","DISV","PJIO","QLVD","HJPX","DMRI","DIHP","LU1152091754.HKD","IDHD","RFDI","01093","KURE","LU1226288253.USD","JHMD","IQSI","PCIG","03308","BBIN","VXUS","IHDG","FEOE","HDEF","UIVM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665142623","title":"CSPC Pharma Begins Phase II Study of Influenza Drug in China","url":"https://stock-news.laohu8.com/highlight/detail?id=2665142623","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665142623?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:11","pubTimestamp":1788786661,"startTime":"0","endTime":"0","summary":"CSPC Pharmaceutical Group (HKG:1093) began a phase II clinical trial of SYH2085 tablets in China.The drug was developed by the company to treat uncomplicated influenza in adults, according to a Monday bourse filing.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0326950275.SGD","LU1152091754.HKD","IE0008368742.USD","IE00B031HY20.USD","LU1807302812.USD","HK0000165453.HKD","IE00B5MMRT66.SGD","LU1993786604.SGD","BK1515","BK1191","LU1226287792.SGD","IE00BZ08YS42.EUR","IE00B543WZ88.USD","LU0072913022.USD","LU1152091168.USD","01093","IE0008369823.USD","LU1226287875.USD","LU0314109678.HKD","LU1960683339.HKD","LU1226287529.USD","SG9999004220.SGD","LU0067412154.USD","IE00BZ08YT58.USD","LU1951186391.HKD","LU1008478684.HKD","BK1521","LU1226288170.HKD","LU0140636845.USD","KURE","LU2039709279.SGD","LU1226288253.USD","LU1328277881.USD","IE00BZ08YR35.GBP","LU0880133367.SGD","LU0315179316.USD","LU0501845795.SGD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1111207955","title":"Fourth Breakthrough Therapy Designation Granted to EGFR-Targeted ADC Developed by CSPC","url":"https://stock-news.laohu8.com/highlight/detail?id=1111207955","media":"Deep News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111207955?lang=en_us&edition=fundamental","pubTime":"2026-09-07 21:01","pubTimestamp":1788786078,"startTime":"0","endTime":"0","summary":"On September 7th, the CDE website revealed that SYS6010, developed by CSPC PHARMA, has been proposed for inclusion in the breakthrough therapy designation program. This designation is intended for...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1993786604.SGD","LU2039709279.SGD","IE00BZ08YR35.GBP","LU1226288253.USD","LU1960683339.HKD","LU1152091754.HKD","LU1226288170.HKD","01093","BK1521","LU1226287529.USD","LU1226287875.USD","LU0072913022.USD","BK1515","IE00B5MMRT66.SGD","LU1951186391.HKD","BK1191","LU1807302812.USD","LU0315179316.USD","IE00B031HY20.USD","IE00BZ08YS42.EUR","LU0501845795.SGD","HK0000165453.HKD","IE0008368742.USD","LU0314109678.HKD","SG9999004220.SGD","LU0326950275.SGD","LU1008478684.HKD","LU1328277881.USD","LU0067412154.USD","LU1152091168.USD","LU1226287792.SGD","KURE","LU0140636845.USD","IE00B543WZ88.USD","IE0008369823.USD","LU0880133367.SGD","IE00BZ08YT58.USD","LU1813983027.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665145523","title":"WuXi Biologics Files HKEX Next-Day Disclosure Return, Issues 1,804,090 New Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2665145523","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665145523?lang=en_us&edition=fundamental","pubTime":"2026-09-07 20:53","pubTimestamp":1788785616,"startTime":"0","endTime":"0","summary":"WuXi Biologics files HKEX next-day disclosure return, issues 1,804,090 new sharesWuXi Biologics filed a next-day disclosure return on Sept. 7, 2026 following option exercises under its pre-IPO share o","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260907:nNDL8NH0rN:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0326950275.SGD","LU0456827905.SGD","LU0320764599.SGD","BK1589","LU0359201612.USD","LU0417516902.SGD","LU0572944931.SGD","LU0516423091.SGD","LU1688375341.USD","LU1242518857.USD","SG9999002463.SGD","BK1141","LU0307460666.USD","LU0417516738.SGD","LU0052750758.USD","LU1720050803.USD","SG9999002562.SGD","BK1576","LU1794554557.SGD","LU0516422952.EUR","LU0128526141.USD","LU0979878070.USD","LU0051755006.USD","LU0516422440.USD","LU0708995583.HKD","LU1880383366.USD","LU0348735423.USD","LU3063872942.SGD","LU0856984785.SGD","LU0823426308.USD","LU0819121731.USD","02269","BK1521","LU0029874061.USD","LU0327786744.USD","LU0140636845.USD","KURE","LU0359202008.SGD","IE00B0JY6N72.USD","LU0588546209.SGD","LU2039709279.SGD","LU0043850808.USD","LU0181495838.USD","LU0823426480.USD","LU1242518931.SGD","LU0456846285.SGD","LU0516422366.SGD","LU0348825331.USD","LU0039217434.USD","LU0516423174.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1199113939","title":"CSPC Pharma Initiates Phase II Trial of SYH2085 Tablet for Uncomplicated Influenza in Chinese Adults","url":"https://stock-news.laohu8.com/highlight/detail?id=1199113939","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1199113939?lang=en_us&edition=fundamental","pubTime":"2026-09-07 19:36","pubTimestamp":1788780985,"startTime":"0","endTime":"0","summary":"CSPC Pharma (01093) has announced that the Phase II clinical trial of its SYH2085 tablet, designed for the treatment of uncomplicated influenza in adults, has formally commenced at the first clinical...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE0008369823.USD","IE00BZ08YT58.USD","LU1226287792.SGD","IE00BZ08YR35.GBP","LU1226287875.USD","LU1226288170.HKD","01093","LU0314109678.HKD","LU0880133367.SGD","LU0067412154.USD","LU1993786604.SGD","LU0140636845.USD","LU1226288253.USD","BMED","BK1515","LU1152091168.USD","LU1807302812.USD","LU1008478684.HKD","LU1813983027.USD","LU0501845795.SGD","LU0326950275.SGD","PSYK","LU1960683339.HKD","IBBJ","IE00B5MMRT66.SGD","KURE","LU0072913022.USD","IE00B543WZ88.USD","MDTX","IBBQ","LU0315179316.USD","LU1152091754.HKD","LU1951186391.HKD","SG9999004220.SGD","BK1191","BK1521","IE00BZ08YS42.EUR","HK0000165453.HKD","IE0008368742.USD","LU2039709279.SGD","LU1226287529.USD","LU1328277881.USD","IE00B031HY20.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665339005","title":"Wuxi Biologics (Cayman) Stock Slides 1.4% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2665339005","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2665339005?lang=en_us&edition=fundamental","pubTime":"2026-09-07 16:32","pubTimestamp":1788769920,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Wuxi Biologics  Inc. shed 1.4% to 48.48 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.9% to 25413.12.This was the stock's second consecutive day of losses.Wuxi Biologics  Inc. closed 11% short of its 52-week high of HK$54.45, which the company reached Aug. 26.Trading volume totaled 26.7 million shares, compared to the 50-day average of 38.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0307460666.USD","LU0823426308.USD","BK1141","LU0516422366.SGD","LU0588546209.SGD","LU1242518857.USD","LU0140636845.USD","LU1720050803.USD","BK1521","LU0572944931.SGD","SG9999002562.SGD","LU0456846285.SGD","LU0326950275.SGD","02269","LU0052750758.USD","LU0823426480.USD","LU1688375341.USD","LU2039709279.SGD","LU0128526141.USD","LU0359202008.SGD","IE00B0JY6N72.USD","LU0359201612.USD","LU0417516902.SGD","LU0516423174.USD","LU0708995583.HKD","LU0856984785.SGD","LU0516423091.SGD","BK1589","LU0039217434.USD","LU0417516738.SGD","LU0327786744.USD","LU0516422952.EUR","LU1880383366.USD","LU0043850808.USD","KURE","LU0516422440.USD","BK1576","BK1610","LU0979878070.USD","LU0051755006.USD","LU0348735423.USD","LU0181495838.USD","LU1794554557.SGD","SG9999002463.SGD","LU0320764599.SGD","LU0456827905.SGD","LU1242518931.SGD","LU0819121731.USD","LU3063872942.SGD","LU0348825331.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1109390642","title":"UBS Flags Strong H1 Sales for Chinese Biotech Despite Regulatory Headwinds, Eyes Late-Year Catalysts","url":"https://stock-news.laohu8.com/highlight/detail?id=1109390642","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1109390642?lang=en_us&edition=fundamental","pubTime":"2026-09-07 09:50","pubTimestamp":1788745830,"startTime":"0","endTime":"0","summary":"UBS has released a research note suggesting that while market expectations for the Chinese biotech sector's first-half results were initially conservative—due to concerns over tighter domestic drug...","market":"fut","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09926","BK1191","688235","BK1500","LU0540923850.HKD","LU1794554557.SGD","LU0588546209.SGD","BK1583","BK1587","LU0196878994.USD","BK0239","LU2097828557.USD","LU0502904849.HKD","HK0000165453.HKD","LU2097828474.EUR","LU0417516902.SGD","ONC","LU0326950275.SGD","LU1770034418.SGD","BK4585","09969","LU0307460666.USD","01877","BK1589","LU2328871848.SGD","06990","LU0348783233.USD","BK1574","01801","BK4588","00013","BK1161","LU1969619763.USD","LU0348735423.USD","LU0417516738.SGD","LU2488822045.USD","KURE","LU0348784397.USD","LU0634319403.HKD","LU0828237510.HKD","06160","LU0348766576.USD","LU0561508036.HKD","LU1961090484.USD","LU2097828714.EUR","LU2399975544.HKD","LU2476274720.SGD","BK4526","LU0455707207.USD","03069","LU2097828805.USD","LU0463099449.HKD","LU0228659784.USD","LU2242644610.SGD","LU1720050803.USD","BK1515","IE00B5MMRT66.SGD","LU0417516571.SGD","LU1188198961.HKD","LU0244354667.USD","LU0348827113.USD","LU1251922891.USD","IE00B543WZ88.USD","LU0348825331.USD","LU2476274308.USD","BK1588","BK4139","LU0348767384.USD","LU2097828631.EUR","LU1719994722.HKD","IE00BPRC5H50.USD","LU2778985437.USD","LU1303224171.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1129584734","title":"Hong Kong Stock Connect Biotech Surges: Dual-Antibody Outperforms Keytruda, Sector Heats Up","url":"https://stock-news.laohu8.com/highlight/detail?id=1129584734","media":"Deep News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1129584734?lang=en_us&edition=fundamental","pubTime":"2026-09-06 19:22","pubTimestamp":1788693744,"startTime":"0","endTime":"0","summary":"The Hong Kong Stock Connect innovative drug sector finally sprung to life on September 4, posting its third consecutive session of gains with rising volume. The HUABAO HANG SENG HONG KONG STOCK...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2476274720.SGD","LU2399975544.HKD","09926","LU0540923850.HKD","IE00B5MMRT66.SGD","LU0348766576.USD","LU0348767384.USD","LU2778985437.USD","LU1794554557.SGD","LU0348825331.USD","LU2476274308.USD","LU0561508036.HKD","LU0348827113.USD","LU0417516902.SGD","LU0417516571.SGD","LU1961090484.USD","520880","BK1161","LU0417516738.SGD","LU0348783233.USD","LU0348784397.USD","LU0348735423.USD","IE00B543WZ88.USD","LU0634319403.HKD","LU1720050803.USD","LU2488822045.USD","BK1574","KURE","IE00BPRC5H50.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188865864","title":"Loose Fed Bets and AI Monetization Fuel Hong Kong Stocks Rally","url":"https://stock-news.laohu8.com/highlight/detail?id=1188865864","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188865864?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:16","pubTimestamp":1788524178,"startTime":"0","endTime":"0","summary":"Hong Kong stocks ended the session firmly in positive territory, closing up 1.74% after a strong open, though momentum faded slightly into the close. The overnight surge on Wall Street, where all...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PBDC","KBE","LU0348825331.USD","IEF","LU2476274720.SGD","TLH","SGOV","FAZ","02714","LU0540923850.HKD","IGOV","BK4504","LU1794554557.SGD","SPDN","WAMA","GOLY","USHY","BSV","TBT","MINT","BIL","AGG","BOXX","BBLB","LIAJ","SDS","BK1574","HYGU","UBT","MYCN","TFJL","SKRE","XBIL","XLF","MUNX","VGSH","VCIT","09926","KCAI","NGHT","SPXU","LU0348784397.USD","BK1161","BBSB","SMAX","TLTI","EDV","LU2778985437.USD","BK4588","SPYU","UUP","09678","BK4585","GOVT","BND","ZBmain","TMF","JULD","SPY","LU2476274308.USD","JPST","ZROZ","LQD","LU0348783233.USD","02698","02419","CIVG","BK4534","SCHO","BK1237","IAT","UBmain","KRE","BK1207","IE00B5MMRT66.SGD","BWZ","LU1961090484.USD","DPST","TLTX","LQDD","BBIB","EBUF","LU0561508036.HKD","IEI","ISHG","SPUU","HYGD","SPXL","SPYI","TIP","FEM","TLT","BK4581","SPYH","TSYW","KRX","KBWB","LU2399975544.HKD","BK4561","KURE","LU0348766576.USD","VCSH","YSPY","VGIT","TBJL","HIBL","SSO","HMOP","ZTmain","IVV","NEMD","NELS","UPRO","TNmain","ZFmain","TLTW","IE00B543WZ88.USD","BK1109","VOO","HYG","MESmain","OEX","BWX","SPXS","SPYQ","SPYM","LU0348767384.USD","MMAX","UDN","SHY","GBIL","ESmain","LU1720050803.USD","VFH","IE00BPRC5H50.USD","TBIL","FLGV","BOND","VXUS","EMPB","DBND","RAUS","VEXC","LU0417516902.SGD","TYO","LU0348827113.USD","OOQB","LU0417516738.SGD","SHV","MUB","LU2488822045.USD","HK0000165453.HKD","LU0634319403.HKD","OEF","VGLT","LU0417516571.SGD","DMAX","BK4559","XLRI","BK4535","BK1160","LU0348735423.USD","SH",".SPX","LQDU","BK4550","SPYB"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1115414825","title":"WuXi Bio Issues 3.2 Million Shares Following Option Exercise","url":"https://stock-news.laohu8.com/highlight/detail?id=1115414825","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115414825?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:00","pubTimestamp":1788523219,"startTime":"0","endTime":"0","summary":"WUXI BIO (02269) has announced the issuance of 3.2 million new ordinary shares pursuant to the exercise of options under the company's pre-IPO share option scheme.The scheme was originally adopted on...","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1141","BK1610","LU0327786744.USD","LU0819121731.USD","LU1880383366.USD","LU0348825331.USD","BK1521","LU0823426308.USD","LU0326950275.SGD","LU1794554557.SGD","BK1576","LU0359201612.USD","LU0516423091.SGD","LU1720050803.USD","LU0140636845.USD","LU0516422952.EUR","LU0588546209.SGD","SG9999002562.SGD","LU0052750758.USD","LU0039217434.USD","LU0307460666.USD","LU2039709279.SGD","BK1589","LU0417516738.SGD","LU0516422440.USD","KURE","LU0417516902.SGD","LU0856984785.SGD","LU0456846285.SGD","LU0029874061.USD","LU0320764599.SGD","LU0051755006.USD","LU0823426480.USD","02269","LU0359202008.SGD","LU0708995583.HKD","LU1242518931.SGD","LU0516422366.SGD","LU3063872942.SGD","LU0181495838.USD","LU0456827905.SGD","LU0043850808.USD","IE00B0JY6N72.USD","LU1242518857.USD","LU1688375341.USD","LU0348735423.USD","LU0516423174.USD","LU0572944931.SGD","LU0979878070.USD","SG9999002463.SGD","LU0128526141.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664336568","title":"Wall Street Cues, Easing Bond Yields Boost Asian Stock Markets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664336568","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664336568?lang=en_us&edition=fundamental","pubTime":"2026-09-04 18:38","pubTimestamp":1788518285,"startTime":"0","endTime":"0","summary":"Asian stock markets largely traded higher Friday, after overnight gains on Wall Street, and as bond yields softened.Led by tech issues, Hong Kong and Tokyo finished in the green, although Shanghai edg","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU0043850808.USD","LU0856984785.SGD","07200","07300","MHImain","513600","LU0140636845.USD","02800","LU0052750758.USD","LU0327786744.USD","LU0823426308.USD","LU0348767384.USD","LU0572944931.SGD","LU0417516902.SGD","LU0516423174.USD","LU0979878070.USD","LU0029874061.USD","02269","07500","82800","SG9999002562.SGD","02833","BK1141","LU0128526141.USD","LU0456846285.SGD","LU1720050803.USD","LU0326950275.SGD","BK1521","LU0320764599.SGD","LU2039709279.SGD","LU0823426480.USD","LU1880383366.USD","LU0039217434.USD","LU0516422366.SGD","LU1242518931.SGD","MCHmain","BK1576","09115","LU0348735423.USD","LU0348766576.USD","LU0348825331.USD","BK1555","BK1589","LU0181495838.USD","LU1688375341.USD","LU0819121731.USD","83115","LU0516423091.SGD","LU0588546209.SGD","LU0708995583.HKD","LU3063872942.SGD","WXXWY","HHImain","03419","HSI","BK1240","IE00B0JY6N72.USD","LU0307460666.USD","LU0359202008.SGD","LU1242518857.USD","LU0516422440.USD","SG9999002463.SGD","03115","KURE","LU0456827905.SGD","HSTECH","LU0516422952.EUR","00960","BK1610","LU0051755006.USD","LU0417516738.SGD","LU0359201612.USD","LGFRY","03037","LU1794554557.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1155688836","title":"Daiwa Highlights AKESO's HARMONi-2 Milestone, Bolstering Case for Global NSCLC Study Success","url":"https://stock-news.laohu8.com/highlight/detail?id=1155688836","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1155688836?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:24","pubTimestamp":1788506656,"startTime":"0","endTime":"0","summary":"Daiwa has released a research report noting that the pre-specified interim overall survival (OS) analysis for AKESO's (09926) Phase III study of ivonescimab as a first-line treatment for...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0540923850.HKD","BK1574","LU2476274720.SGD","LU0634319403.HKD","IE00B543WZ88.USD","LU0348766576.USD","LU0348825331.USD","LU0348767384.USD","LU1720050803.USD","IE00BPRC5H50.USD","LU2476274308.USD","LU0561508036.HKD","LU0417516902.SGD","LU0348827113.USD","IE00B5MMRT66.SGD","LU2399975544.HKD","LU0348735423.USD","LU2778985437.USD","LU1794554557.SGD","LU0417516738.SGD","LU0348784397.USD","LU1961090484.USD","LU0348783233.USD","BK1161","KURE","LU2488822045.USD","09926"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141408111","title":"Brokerage Adds Tencent and Innovent Bio to Buy List While Maintaining Positive Outlook on Tech and Hardware Sectors","url":"https://stock-news.laohu8.com/highlight/detail?id=1141408111","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141408111?lang=en_us&edition=fundamental","pubTime":"2026-09-04 13:34","pubTimestamp":1788500064,"startTime":"0","endTime":"0","summary":"UOB Kay Hian's latest research report indicates that mainland Chinese equities underwent a consolidation phase during August, with the Hang Seng Index and MSCI China Index retreating 1.2% and 0.4%...","market":"other","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B031HY20.USD","LU1046422090.SGD","LU0328353924.USD","IE0008368411.USD","BK0187","IE00BZ08YT58.USD","LU0856984785.SGD","LU0918141705.HKD","LU0648948544.HKD","LU2045819591.USD","LU0259732245.USD","LU0821914370.USD","LU2039709279.SGD","BIDD","LU0823040885.USD","SG9999000459.SGD","BKF","LU0169518387.USD","LU0683595622.HKD","LU2087589342.USD","LU1733274473.HKD","LU0084288322.USD","BK1604","CXSE","LU2476274720.SGD","LU1814569148.SGD","LU2153591404.USD","SG9999001903.USD","LU1048484197.HKD","LU2449936058.SGD","BK1161","LU1242518857.USD","IE00B8L5B284.USD","LU1255011170.USD","IE00BGV7N243.SGD","LU1720050803.USD","LU0235996351.USD","LU1439103000.SGD","LU0345769128.USD","LU2148510915.USD","LU1152091168.USD","FDNI","LU1226287875.USD","LU0348816934.USD","LU1044876610.USD","LU0228367735.SGD","BK1517","LU0819121731.USD","LU0588546209.SGD","LU0048580855.USD","LU0231483743.USD","LU0819123356.HKD","LU0261950470.USD","SGXZ81514606.USD","BK0201","LU2247934214.USD","BK0132","LU0417516738.SGD","LU0605514214.HKD","LU0345769631.USD","U10.SI","LU0348827113.USD","LU0127658192.USD","LU0348784397.USD","LU0348783662.USD","LU1880383440.USD","LU0192582467.USD","LU0314109678.HKD","ONC","LU0543330566.HKD","GB00BDT5M118.USD","LU0593848301.USD","BK1526","LU0634319403.HKD","LU1997244956.HKD","BK0188","LU1282648689.USD","LU0149721374.USD","LU0345776255.USD","LU0261950983.USD","LU2495084118.USD","LU2125910849.SGD","LU2133065610.SGD","LU2097828631.EUR","LU0797268264.HKD","LU1323998911.USD","BK1095","SG9999001069.SGD","BK1583","LU0203347892.USD","BK1586","LU0823038988.USD","JEMA","SG9999000475.SGD","HK0000320223.HKD","LU1115378108.SGD","LU1960683339.HKD","LU1675838814.USD","LU0738912210.USD","LU0737861772.HKD","HK0000914660.USD","LU1568876335.HKD","LU0274383776.USD","LU1981816686.USD","LU0107464264.USD","EMC","LU1328615791.USD","LU1224709979.USD","LU0488056044.USD","00700","300014","IE00B0JY6N72.USD","LU0326948709.USD","LU0456827905.SGD","LU0348723411.USD","IE0032834883.USD","LU0051755006.USD","LU0315178854.USD","09961","LU1051768304.USD","LU2089985449.USD","LU1868837722.USD","LU2279858448.HKD","LU2362540622.SGD","LU2362541273.HKD","LU0868486357.SGD","LU0181495838.USD","LU0502904849.HKD","LU1102505762.USD","LU0348825331.USD","LU0049112450.USD","LU0499858438.USD","LU0326950275.SGD","SG9999002828.SGD","SG9999000327.SGD","LU0348788117.USD","LU0132412106.USD","BK1588","LU0589944569.HKD","IE0003851619.USD","BK1610","IE0008369823.USD","IE00B067MR52.USD","LU0823041008.USD","LU0128522744.USD","IE0001KFT4U8.USD","LU0588545490.SGD","HK0000151867.HKD","LU1961090484.USD","SG9999001689.USD","LU0708995153.HKD","IE0032431581.USD","LU0642271901.SGD","LU1303224171.USD","BK0028","LU0672654166.SGD","SG9999002406.SGD","BK0196","LU0608807946.USD","LU2279701549.SGD","LU0865486749.SGD","SG9999006514.SGD","LU0251144936.SGD","LU0048575426.USD","LU0650527681.SGD","BK1589","LU2226246903.HKD","LU0499858602.USD","BK0077","BK0251","LU1974910355.USD","LU0210526637.USD","LU0329678170.USD","LU0359201885.HKD","GAMR","HK0000352382.USD","LU0196878994.USD","LU1997245177.USD","SGXZ49509284.SGD","LU0052750758.USD","LU1719994722.HKD","SG9999001093.SGD","SG9999007991.SGD","LU1282649141.HKD","LU1993786604.SGD","LU0261947096.USD","LU0417516902.SGD","LU2237443622.USD","BK1618","LU1251922891.USD","LU0455707207.USD","LU0882747503.HKD","IE00B543WZ88.USD","LU0791590937.USD","BK0064","LU0633140560.USD","SG9999014914.USD","LU1048588211.SGD","SG9999014898.SGD","LU0509642566.USD","LU1008478684.HKD","SG9999018865.SGD","LU0072462343.USD","LU1226288170.HKD","LU1883866441.USD","LU0675040207.SGD","IE0031814852.USD","LU0269904917.USD","LDEM","LU0117844026.USD","BK0224","LU0128522157.USD","LU1956131251.USD","BK1591","LU2237443978.SGD","IE00BQXX3D17.EUR","LU0463099449.HKD","EVS.SI","IE00B0169N27.USD","LU0140636845.USD","LU2506952253.HKD","LU0106259558.USD","LU0229945570.USD","BK0152","LU1655091459.SGD","LU0516423091.SGD","LU0886674414.USD","LU2462611646.USD","LU0873338254.USD","LU0048388663.USD","LU1064130708.USD","LU1807302812.USD","LU2242644610.SGD","TCOM","LU0541501648.USD","SG9999002562.SGD","LU2023250504.SGD","LU0456842615.SGD","LU1196710351.USD","HK0001040143.USD","LU0516422366.SGD","LU0307460666.USD","LU1997245094.SGD","IE0003895053.USD","LU2097828474.EUR","LU0096374516.USD","LU0414403682.SGD","LU2424517915.HKD","LU1152091754.HKD","LU0345775950.USD","BK1609","LU0070217475.USD","LU0106252389.USD","BK1164","LU2476274308.USD","LU1733274390.USD","LU0188438112.USD","LU0072913022.USD","IE00B031HW06.USD","LU0211331839.USD","LU1226287792.SGD","LU1718418525.SGD","BK6044","LU1039395188.USD","LU0516422952.EUR","SG9999000418.SGD","LU0054237671.USD","LU1064131003.USD","BK0155","SGXZ99366536.SGD","LU0348805143.USD","LU1794554557.SGD","LU2348773727.SGD","LU0211977185.USD","002008","LU0577902538.SGD","LU0979878070.USD","LU0061477393.USD","LU1366334651.USD","AAXJ","IE00B29SXG58.USD","LU1366334578.USD","LU0244354667.USD","IE00BZ08YS42.EUR","LU1146622755.USD","LU0469268626.HKD","LU1655091616.SGD","LU0786609619.USD","SG9999011746.SGD","KWEB","SG9999001846.SGD","LU0871576103.HKD","LU0173614495.USD","LU0823397285.USD","BK0070","HK0000320264.USD","LU1226287529.USD","LU2051468812.USD","JADE","LU0823397103.USD","LU0651946864.USD","LU0516423174.USD","LU0143863198.USD","LU0143863784.USD","LU1171460220.USD","LU0640798160.USD","LU1629966141.USD","LU3063872942.SGD","LU2097828714.EUR","SG9999003461.SGD","BK1531","LU0572939691.SGD","LU1211504680.USD","HK0000914686.HKD","LU0784639295.USD","LU0898667661.SGD","LU0880133367.SGD","LU0348783233.USD","LU0165289439.USD","HK0000165453.HKD","IE0009570106.USD","LU0791591158.USD","LU0164880469.USD","LU0918141887.USD","LU1868837565.USD","LU2399975544.HKD","LU0080751232.USD","LU1224444064.USD","LU1770036033.HKD","LU0067412154.USD","LU0417516571.SGD","LU0543330483.HKD","SG9999004220.SGD","SG9999015952.SGD","LU0106959298.USD","LU0359202008.SGD","IE00B97KM107.HKD","BK0073","LU1568876251.USD","LU0384037296.USD","LU1951186391.HKD","LU0117841782.USD","LU0823426308.USD","LU0370786039.SGD","LU0878004406.USD","LU0531970944.HKD","LU0633140727.USD","LU2152927971.USD","SG9999014906.USD","688235","LU1044875133.USD","LU0828238088.HKD","LU0049853897.USD","HK0000288784.HKD","LU0985320562.USD","LU1282649067.USD","LU1642822792.SGD","LU1102505929.USD","LU2237443465.HKD","LU1439102457.SGD","LU2778985437.USD","SG9999015945.SGD","LU2317271919.USD","LU1810669033.SGD","LU2293587155.HKD","EEMX","LU2097828557.USD","BK1608","LU2125910500.SGD","LU1282651048.USD","LU2177674079.SGD","LU2251237488.HKD","LU0163747925.USD","LU1515016050.SGD","LU1196710864.SGD","LU2237443549.SGD","LU1769817179.HKD","LU0577902371.SGD","IE00B8HQ1Z84.USD","LU0501845795.SGD","FFEM","SGXZ81163826.USD","LU0607220059.USD","BK1500","BK1502","LU1051769294.HKD","SG9999018857.SGD","LU1044874839.SGD","IE00BF5LJ272.USD","LU0210527791.USD","LU0039217434.USD","LU0972618739.USD","LU0029874905.USD","LU1691799644.USD","LU0449509016.USD","LU2362541513.USD","LU0449515922.USD","LU0540923850.HKD","LU1282651121.HKD","SGXZ51526630.SGD","LU0708995583.HKD","LU1808992512.USD","ODDS","01801","LU0651947912.USD","LU0287142896.SGD","LU0831103253.SGD","LU0577902611.USD","LU0214875030.USD","LU0611395673.USD","LU1785774172.SGD","LU1781817850.SGD","LU2498475776.HKD","SG9999015986.USD","LU0577902454.USD","LU0456846285.SGD","LU0396098781.USD","LU0823413660.USD","LU1328277881.USD","LU0878005551.USD","LU0431992006.USD","LU0700851271.USD","SG9999006597.SGD","EMCS","BK1521","KURE","HTCD.SI","HK0000352291.HKD","SG9999002463.SGD","LU0164872284.USD","XSOE","LU1880383366.USD","LU1688375341.USD","LU0823413587.USD","LU2097828805.USD","LU0320764599.SGD","LU0149534421.HKD","LU0588545730.USD","LU1504937902.USD","LU0203345920.USD","LU0329678337.USD","LU0289960550.SGD","LU2289578879.USD","IE00BZ08YR35.GBP","SG9999017495.SGD","SGXZ90724238.SGD","LU0516422440.USD","HK0000288743.USD","BK1587","IE00BQXX3F31.USD","LU1813983027.USD","LU0264606111.USD","LU0175139822.USD","LU0359201612.USD","LU0862451753.SGD","SGXZ31699556.SGD","LU0561508036.HKD","BK0072","HK0000306701.USD","LU1969619763.USD","LU0594300419.USD","LU2251237306.USD","LU2265009873.SGD","TCEHY","LU1868838027.USD","002371","LU1769817096.USD","LU0029875118.USD","LU1226288097.SGD","LU1725190679.HKD","LU1831875114.USD","BK1615","LU0541502299.USD","SG9999001226.SGD","IE00BQXX3C00.GBP","LU1188198961.HKD","LU1226288253.USD","LU0828237510.HKD","06160","TCHI","SOCL","LU1770034418.SGD","IE00B031J352.USD","LU3227948356.SGD","LU1316542783.SGD","LU0531971595.HKD","IE0003795394.USD","LU0254981946.USD","LU1196710195.USD","LU0293314216.USD","IE00B5MMRT66.SGD","LU0588545904.SGD","LU2931357623.SGD","BK0125","HK0000306685.HKD","LU2106854487.HKD","IE0034224299.USD","LU0441854154.USD","LU0228659784.USD","LU2488822045.USD","BK1516","LU1734074674.USD","LU1235295612.USD","LU2237443895.HKD","LU2257852520.SGD","LU0320764243.SGD","LU0608807433.USD","LU0823039010.USD","LU0348735423.USD","HK0001040168.HKD","LU2328871848.SGD","LU0577902298.EUR","SG9999013353.USD","LU1242518931.SGD","LU1917777945.USD","LU1820825898.SGD","LU0737861699.HKD","SG9999015978.USD","LU1023057109.AUD","LU0251143458.SGD","LU0890818403.SGD","LU2294711473.HKD","LU0043850808.USD","LU0594300179.USD","SG9999001051.SGD","IE00B3M56506.USD","IE00B0169L03.USD","SG9999014674.SGD","BK6516","LU0862451837.USD","LU0210533765.USD","LU0011963245.USD","LU0348814723.USD","LU0047713382.USD","IE00BPRC5H50.USD","LU2237443382.USD","LU0828237940.HKD","LU0164865239.USD","LU1105468828.SGD","LU0054450605.USD","LU0048597586.USD","ESPO","LU0315179316.USD","LU1804176565.USD","LU0572940350.SGD","LU0327786744.USD","LU0823426480.USD","IE0008368742.USD","LU1580142542.USD","LU1282649810.SGD","LU0572944931.SGD","SG9999014880.SGD","LU0823437842.USD","BK0061","LU2008162690.USD","LU1048596156.SGD","LU1481107354.HKD","LU0320764755.SGD","SG9999002414.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":2,"totalSize":200,"code":"91000000","status":"200"}]}}